Literature DB >> 21291364

Lactoferrin: a biologically active molecule for bone regeneration.

A A Amini1, L S Nair.   

Abstract

Lactoferrin, a member of the "Siderophilin" family, is an iron binding glycoprotein. Lactoferrin is produced by various exocrine glands in our body and is abundantly present in milk and colostrums. The uniqueness of lactoferrin as a skeletal regenerative molecule lies in its ability to favorably modulate the responses of the various cell types involved in musculoskeletal regeneration. Lactoferrin exhibits pleiotropic functions and recent studies indicate that lactoferrin promotes the proliferation and differentiation of osteoblast cells and inhibits osteoclast-mediated bone resorption. Human lactoferrin is also known to promote neovascularization. This review aims to summarize the most recent studies on lactoferrin focusing on its anabolic effect to bone tissue and the ability to modulate immune responses with specific focus on osteoimmunology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21291364     DOI: 10.2174/092986711795029744

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  11 in total

1.  Lactoferrin inhibits apoptosis through insulin-like growth factor I in primary rat osteoblasts.

Authors:  Jian-ming Hou; En-yu Chen; Shi-chao Wei; Fan Lin; Qing-ming Lin; Xu-hua Lan; Ying Xue; Man Wu
Journal:  Acta Pharmacol Sin       Date:  2014-02-24       Impact factor: 6.150

2.  Recombinant human lactoferrin as a biomaterial for bone tissue engineering: mechanism of antiapoptotic and osteogenic activity.

Authors:  Ashley A Amini; Lakshmi S Nair
Journal:  Adv Healthc Mater       Date:  2013-12-18       Impact factor: 9.933

3.  Evaluation of the bioactivity of recombinant human lactoferrins toward murine osteoblast-like cells for bone tissue engineering.

Authors:  Ashley A Amini; Lakshmi S Nair
Journal:  Tissue Eng Part A       Date:  2013-02-19       Impact factor: 3.845

4.  Lactoferrin promote primary rat osteoblast proliferation and differentiation via up-regulation of insulin-like growth factor-1 expression.

Authors:  Jian-ming Hou; Man Wu; Qing-ming Lin; Fan Lin; Ying Xue; Xu-hua Lan; En-yu Chen; Mei-li Wang; Hai-yan Yang; Feng-xiong Wang
Journal:  Mol Biol Rep       Date:  2014-05-03       Impact factor: 2.316

5.  Development of dairy herd of transgenic goats as biofactory for large-scale production of biologically active recombinant human lactoferrin.

Authors:  I Semak; A Budzevich; E Maliushkova; V Kuzniatsova; N Popkov; I Zalutsky; O Ivashkevich
Journal:  Transgenic Res       Date:  2019-08-08       Impact factor: 2.788

6.  Enzymatically cross-linked bovine lactoferrin as injectable hydrogel for cell delivery.

Authors:  Ashley A Amini; Ho-Man Kan; Zhanwu Cui; Peter Maye; Lakshmi S Nair
Journal:  Tissue Eng Part A       Date:  2014-06-16       Impact factor: 3.845

7.  Coupling Hydroxyapatite Nanocrystals with Lactoferrin as a Promising Strategy to Fine Regulate Bone Homeostasis.

Authors:  Monica Montesi; Silvia Panseri; Michele Iafisco; Alessio Adamiano; Anna Tampieri
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

8.  Local application of lactoferrin promotes bone regeneration in a rat critical-sized calvarial defect model as demonstrated by micro-CT and histological analysis.

Authors:  Ryan Gao; Maureen Watson; Karen E Callon; Donna Tuari; Michael Dray; Dorit Naot; Satya Amirapu; Jacob T Munro; Jillian Cornish; David S Musson
Journal:  J Tissue Eng Regen Med       Date:  2017-04-09       Impact factor: 3.963

9.  Activation of TGF-β Canonical and Noncanonical Signaling in Bovine Lactoferrin-Induced Osteogenic Activity of C3H10T1/2 Mesenchymal Stem Cells.

Authors:  Yixuan Li; Wei Zhang; Fazheng Ren; Huiyuan Guo
Journal:  Int J Mol Sci       Date:  2019-06-13       Impact factor: 5.923

Review 10.  Pomegranate fruit as a rich source of biologically active compounds.

Authors:  Sreeja Sreekumar; Hima Sithul; Parvathy Muraleedharan; Juberiya Mohammed Azeez; Sreeja Sreeharshan
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.